PepGen (PEPG) Accounts Payables (2021 - 2026)
PepGen (PEPG) reported Accounts Payables of $622000.0 for Q1 2026, down 76.95% on a YoY basis from $2.7 million in Q1 2025, and down 24.33% sequentially from $822000.0 in Q4 2025.
PepGen (PEPG) Accounts Payables (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Accounts Payables data on file, last reported at $622000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 76.95% year-over-year to $622000.0; the trailing twelve-month figure through Mar 2026 stood at $622000.0 (down 76.95% YoY), and the FY2025 full-year result was $822000.0, down 53.08% from the prior year.
- Accounts Payables retreated to $622000.0 in Q1 2026, from $822000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $7.7 million in Q2 2024 to a low of $622000.0 in Q1 2026.
- A 5-year average of $2.6 million and a median of $1.8 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 326.5% in 2024 and plunged 88.94% in 2025, its largest moves.
- Tracing PEPG's Accounts Payables over 5 years: stood at $1.4 million in 2022, then retreated by 26.21% to $1.0 million in 2023, then soared by 74.33% to $1.8 million in 2024, then tumbled by 53.08% to $822000.0 in 2025, then declined by 24.33% to $622000.0 in 2026.
- Business Quant data shows PEPG's Accounts Payables at $622000.0 in Q1 2026, $822000.0 in Q4 2025, and $766000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 622,000.00 |
| Dec 31, 2025 | 822,000.00 |
| Sep 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 856,000.00 |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 5.93 Mn |
| Jun 30, 2024 | 7.74 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 3.24 Mn |